We are live on ! Find out more
DWA

Douglass Winthrop Advisors Portfolio holdings

AUM $5.46B
1-Year Est. Return 11.49%
This Fund
S&P 500
This Quarter Est. Return
+2.9%
1 Year Est. Return
+11.49%
3 Year Est. Return
+66.59%
5 Year Est. Return
+87.07%
10 Year Est. Return
+344%
AUM
$1.48B
AUM Growth
+$35M
Cap. Flow
+$16.6M
Cap. Flow %
1.12%
Top 10 Hldgs %
35.11%
Holding
253
New
9
Increased
86
Reduced
81
Closed
14

Top Buys

Rank Stock Value
1
BUD icon
AB InBev
BUD
+$7.6M
2
COST icon
Costco
COST
+$4.26M
3
AMGN icon
Amgen
AMGN
+$3.26M
4
MKL icon
Markel Group
MKL
+$2.41M
5
CL icon
Colgate-Palmolive
CL
+$2.31M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$13.6M
2
KEY icon
KeyCorp
KEY
+$1.58M
3
WFC icon
Wells Fargo
WFC
+$1.42M
4
DEO icon
Diageo
DEO
+$1.16M
5
EMR icon
Emerson Electric
EMR
+$1.15M

Sector Composition

Rank Sector Weight
1 Financials 20.2%
2 Industrials 13.74%
3 Consumer Staples 13.1%
4 Healthcare 12.78%
5 Technology 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
76
Bristol-Myers Squibb
BMY
$131B
$1.95M 0.13%
33,409
+180
+0.5% +$9.84K
UNP icon
77
Union Pacific
UNP
$173B
$1.93M 0.13%
18,645
+2,699
+17% +$265K
GS icon
78
Goldman Sachs
GS
$301B
$1.91M 0.13%
7,975
-26
-0.3% -$5.28K
KMB icon
79
Kimberly-Clark
KMB
$36.3B
$1.82M 0.12%
15,927
+8,332
+110% +$967K
RTN
80
DELISTED
Raytheon Company
RTN
$1.8M 0.12%
12,666
GILD icon
81
Gilead Sciences
GILD
$161B
$1.78M 0.12%
24,891
+617
+3% +$45.9K
TMO icon
82
Thermo Fisher Scientific
TMO
$210B
$1.77M 0.12%
12,557
-10
-0.1% -$1.47K
COP icon
83
ConocoPhillips
COP
$145B
$1.77M 0.12%
35,307
-5,590
-14% -$258K
MO icon
84
Altria Group
MO
$115B
$1.77M 0.12%
26,172
-52
-0.2% -$3.35K
DHR icon
85
Danaher
DHR
$137B
$1.75M 0.12%
25,397
-483
-2% -$33.5K
ABT icon
86
Abbott
ABT
$181B
$1.68M 0.11%
43,697
+1,359
+3% +$53.9K
CELG
87
DELISTED
Celgene Corp
CELG
$1.66M 0.11%
14,324
+400
+3% +$44.5K
WFC icon
88
Wells Fargo
WFC
$259B
$1.62M 0.11%
29,459
-28,150
-49% -$1.42M
SO icon
89
Southern Company
SO
$109B
$1.6M 0.11%
32,532
-56
-0.2% -$2.75K
INTC icon
90
Intel
INTC
$467B
$1.55M 0.1%
42,698
-362
-0.8% -$13K
NTRS icon
91
Northern Trust
NTRS
$22.4B
$1.54M 0.1%
17,300
KR icon
92
Kroger
KR
$35.6B
$1.49M 0.1%
43,100
+5,990
+16% +$195K
HON icon
93
Honeywell
HON
$76.4B
$1.46M 0.1%
13,913
+2,569
+23% +$261K
DD icon
94
DuPont de Nemours
DD
$18.6B
$1.45M 0.1%
9,975
+118
+1% +$16.4K
F icon
95
Ford
F
$57.7B
$1.42M 0.1%
116,700
+8,196
+8% +$99.4K
LMT icon
96
Lockheed Martin
LMT
$132B
$1.4M 0.09%
5,600
RACE icon
97
Ferrari
RACE
$68.8B
$1.38M 0.09%
23,700
GLW icon
98
Corning
GLW
$121B
$1.36M 0.09%
56,023
TSCO icon
99
Tractor Supply
TSCO
$15.9B
$1.35M 0.09%
89,000
+15,500
+21% +$220K
V icon
100
Visa
V
$681B
$1.34M 0.09%
17,202
+2,400
+16% +$193K

Similar funds

Douglass Winthrop Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, Douglass Winthrop Advisors held 253 positions worth $1.48B, up 2.4% from $1.45B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Douglass Winthrop Advisors's Q4 2016 filing shows 9 new, 86 increased, 81 reduced and 14 closed positions. Its largest new stake was Monsanto Co: 6,752 shares worth $710K. The largest sale was CVS Health, an estimated $13.6M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Staples.

  • Douglass Winthrop Advisors's largest Q4 2016 buy was Monsanto Co: 6,752 shares worth $710K.
  • Douglass Winthrop Advisors added most to AB InBev in Q4 2016, an estimated $7.6M increase.
  • Douglass Winthrop Advisors's biggest Q4 2016 reduction was CVS Health, cutting an estimated $13.6M.
  • Douglass Winthrop Advisors fully exited Enterprise Products Partners in Q4 2016, selling an estimated $739K.
  • Douglass Winthrop Advisors's ten largest holdings make up 35% of its $1.48B portfolio in Q4 2016.
  • Douglass Winthrop Advisors opened 9 new positions and closed 14 in Q4 2016.
  • Douglass Winthrop Advisors's portfolio value rose 2.4% quarter-over-quarter to $1.48B.

Based on Douglass Winthrop Advisors's 13F filing for Q4 2016, filed 31 Jan 2017.